BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 27628668)

  • 1. Plasmablasts During Acute Dengue Infection Represent a Small Subset of a Broader Virus-specific Memory B Cell Pool.
    Appanna R; Kg S; Xu MH; Toh YX; Velumani S; Carbajo D; Lee CY; Zuest R; Balakrishnan T; Xu W; Lee B; Poidinger M; Zolezzi F; Leo YS; Thein TL; Wang CI; Fink K
    EBioMedicine; 2016 Oct; 12():178-188. PubMed ID: 27628668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. B Cell Responses during Secondary Dengue Virus Infection Are Dominated by Highly Cross-Reactive, Memory-Derived Plasmablasts.
    Priyamvada L; Cho A; Onlamoon N; Zheng NY; Huang M; Kovalenkov Y; Chokephaibulkit K; Angkasekwinai N; Pattanapanyasat K; Ahmed R; Wilson PC; Wrammert J
    J Virol; 2016 Jun; 90(12):5574-85. PubMed ID: 27030262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasmablasts generated during repeated dengue infection are virus glycoprotein-specific and bind to multiple virus serotypes.
    Xu M; Hadinoto V; Appanna R; Joensson K; Toh YX; Balakrishnan T; Ong SH; Warter L; Leo YS; Wang CI; Fink K
    J Immunol; 2012 Dec; 189(12):5877-85. PubMed ID: 23152560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower IgG somatic hypermutation rates during acute dengue virus infection is compatible with a germinal center-independent B cell response.
    Godoy-Lozano EE; Téllez-Sosa J; Sánchez-González G; Sámano-Sánchez H; Aguilar-Salgado A; Salinas-Rodríguez A; Cortina-Ceballos B; Vivanco-Cid H; Hernández-Flores K; Pfaff JM; Kahle KM; Doranz BJ; Gómez-Barreto RE; Valdovinos-Torres H; López-Martínez I; Rodriguez MH; Martínez-Barnetche J
    Genome Med; 2016 Feb; 8(1):23. PubMed ID: 26917418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunophenotyping and Transcriptional Profiling of Human Plasmablasts in Dengue.
    Aggarwal C; Saini K; Reddy ES; Singla M; Nayak K; Chawla YM; Maheshwari D; Singh P; Sharma P; Bhatnagar P; Kumar S; Gottimukkala K; Panda H; Gunisetty S; Davis CW; Kissick HT; Kabra SK; Lodha R; Medigeshi GR; Ahmed R; Murali-Krishna K; Chandele A
    J Virol; 2021 Nov; 95(23):e0061021. PubMed ID: 34523972
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Chosen Few: Only a Subset of Memory B Cells Responds to Secondary Dengue Virus Infections.
    Bhattacharya D; Wong R
    EBioMedicine; 2016 Oct; 12():12-13. PubMed ID: 27743902
    [No Abstract]   [Full Text] [Related]  

  • 7. Protective Capacity of the Human Anamnestic Antibody Response during Acute Dengue Virus Infection.
    Xu M; Züst R; Toh YX; Pfaff JM; Kahle KM; Davidson E; Doranz BJ; Velumani S; Tukijan F; Wang CI; Fink K
    J Virol; 2016 Dec; 90(24):11122-11131. PubMed ID: 27707930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between magnitude of the virus-specific plasmablast response and disease severity in dengue patients.
    Garcia-Bates TM; Cordeiro MT; Nascimento EJ; Smith AP; Soares de Melo KM; McBurney SP; Evans JD; Marques ET; Barratt-Boyes SM
    J Immunol; 2013 Jan; 190(1):80-7. PubMed ID: 23203929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune cell phenotypes associated with disease severity and long-term neutralizing antibody titers after natural dengue virus infection.
    Rouers A; Chng MHY; Lee B; Rajapakse MP; Kaur K; Toh YX; Sathiakumar D; Loy T; Thein TL; Lim VWX; Singhal A; Yeo TW; Leo YS; Vora KA; Casimiro D; Lim B; Tucker-Kellogg L; Rivino L; Newell EW; Fink K
    Cell Rep Med; 2021 May; 2(5):100278. PubMed ID: 34095880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total and Envelope Protein-Specific Antibody-Secreting Cell Response in Pediatric Dengue Is Highly Modulated by Age and Subsequent Infections.
    Toro JF; Salgado DM; Vega R; Rodríguez JA; Rodríguez LS; Angel J; Franco MA; Greenberg HB; Narváez CF
    PLoS One; 2016; 11(8):e0161795. PubMed ID: 27560782
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Approaches to Interrogating the Human Memory B-Cell and Memory-Derived Antibody Repertoire Following Dengue Virus Infection.
    Lyski ZL; Messer WB
    Front Immunol; 2019; 10():1276. PubMed ID: 31244836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rapid and massive virus-specific plasmablast responses during acute dengue virus infection in humans.
    Wrammert J; Onlamoon N; Akondy RS; Perng GC; Polsrila K; Chandele A; Kwissa M; Pulendran B; Wilson PC; Wittawatmongkol O; Yoksan S; Angkasekwinai N; Pattanapanyasat K; Chokephaibulkit K; Ahmed R
    J Virol; 2012 Mar; 86(6):2911-8. PubMed ID: 22238318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection from secondary dengue virus infection in a mouse model reveals the role of serotype cross-reactive B and T cells.
    Zompi S; Santich BH; Beatty PR; Harris E
    J Immunol; 2012 Jan; 188(1):404-16. PubMed ID: 22131327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-Cell Analysis of B Cell/Antibody Cross-Reactivity Using a Novel Multicolor FluoroSpot Assay.
    Hadjilaou A; Green AM; Coloma J; Harris E
    J Immunol; 2015 Oct; 195(7):3490-6. PubMed ID: 26320246
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective serological study on sequential dengue virus serotypes 1 to 4 epidemics in Tainan City, Taiwan, 1994 to 2000.
    Chang SF; Huang JH; Chen LK; Su CL; Liao TL; Chien LJ; Lin TH; Su CJ; Shu PY
    J Microbiol Immunol Infect; 2008 Oct; 41(5):377-85. PubMed ID: 19122918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immunogenicity of tetravalent dengue DNA vaccine in mice pre-exposed to Japanese encephalitis or Dengue virus antigens.
    Prompetchara E; Ketloy C; Keelapang P; Sittisombut N; Ruxrungtham K
    Asian Pac J Allergy Immunol; 2015 Sep; 33(3):182-8. PubMed ID: 26342114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity and immunopathology in dengue virus infections.
    Kurane I; Ennis FE
    Semin Immunol; 1992 Apr; 4(2):121-7. PubMed ID: 1617166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Emerging concepts in dengue pathogenesis: interplay between plasmablasts, platelets, and complement in triggering vasculopathy.
    Nascimento EJ; Hottz ED; Garcia-Bates TM; Bozza F; Marques ET; Barratt-Boyes SM
    Crit Rev Immunol; 2014; 34(3):227-40. PubMed ID: 24941075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chimpanzee Fab fragments and a derived humanized immunoglobulin G1 antibody that efficiently cross-neutralize dengue type 1 and type 2 viruses.
    Goncalvez AP; Men R; Wernly C; Purcell RH; Lai CJ
    J Virol; 2004 Dec; 78(23):12910-8. PubMed ID: 15542643
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of Dengue Virus (DENV)-Specific B Cells in the Response to DENV Serotype 1 Infections, Using Flow Cytometry With Labeled Virions.
    Woda M; Friberg H; Currier JR; Srikiatkhachorn A; Macareo LR; Green S; Jarman RG; Rothman AL; Mathew A
    J Infect Dis; 2016 Oct; 214(7):1001-9. PubMed ID: 27443614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.